- Home
- EXEL vs QRVO Comparison
EXEL vs QRVO Comparison
Compare EXEL & QRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- QRVO
- Stock Information
- Founded
- EXEL 1994
- QRVO 1957
- Country
- EXEL United States
- QRVO United States
- Employees
- EXEL N/A
- QRVO 6200
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- QRVO Semiconductors
- Sector
- EXEL Health Care
- QRVO Technology
- Exchange
- EXEL Nasdaq
- QRVO Nasdaq
- Market Cap
- EXEL 10.4B
- QRVO 8.5B
- IPO Year
- EXEL 2000
- QRVO 1997
- Fundamental
- Price
- EXEL $37.88
- QRVO $86.20
- Analyst Decision
- EXEL Buy
- QRVO Hold
- Analyst Count
- EXEL 22
- QRVO 19
- Target Price
- EXEL $44.00
- QRVO $93.83
- AVG Volume (30 Days)
- EXEL 2.4M
- QRVO 2.1M
- Earning Date
- EXEL 10-28-2025
- QRVO 10-28-2025
- Dividend Yield
- EXEL N/A
- QRVO N/A
- EPS Growth
- EXEL 81.76
- QRVO N/A
- EPS
- EXEL 2.08
- QRVO 0.85
- Revenue
- EXEL $2,230,005,000.00
- QRVO $3,651,078,000.00
- Revenue This Year
- EXEL $9.10
- QRVO $2.23
- Revenue Next Year
- EXEL $12.47
- QRVO $4.34
- P/E Ratio
- EXEL $18.54
- QRVO $106.41
- Revenue Growth
- EXEL 10.73
- QRVO N/A
- 52 Week Low
- EXEL $25.17
- QRVO $49.46
- 52 Week High
- EXEL $49.62
- QRVO $107.33
- Technical
- Relative Strength Index (RSI)
- EXEL 38.92
- QRVO 39.29
- Support Level
- EXEL $38.35
- QRVO $90.03
- Resistance Level
- EXEL $41.44
- QRVO $91.97
- Average True Range (ATR)
- EXEL 0.97
- QRVO 2.89
- MACD
- EXEL -0.26
- QRVO -0.62
- Stochastic Oscillator
- EXEL 2.48
- QRVO 2.44
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About QRVO Qorvo Inc.
Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.